Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Peptide
DRUG
3 trials
Sponsors
University of Yamanashi
, Xiangya Hospital of Central South University
, Egymedicalpedia
Conditions
Dental Caries
Esophageal Cancer
Melanoma (Skin)
Phase 1
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
NCT04072900
Xiangya Hospital of Central South University
Melanoma (Skin)
Start: 2020-04-21
End: 2022-09-01
Target: 30
Updated: 2020-04-28
Evaluation of the Effect of Self-Assembling Peptide P11-4
Completed
NCT05667545
Egymedicalpedia
Dental Caries
Start: 2021-07-01
End: 2021-10-30
Updated: 2023-01-06
Phase 2
A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer
NCT00995358
University of Yamanashi
Esophageal Cancer
Start: 2008-11-30
End: 2011-10-31
Target: 60
Updated: 2009-10-15
Related Papers
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
2012-07-09
115 citations